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ABSTRACT
Retroviruses replicate by converting their positive
sense genomic RNA into double-stranded DNA that
is subsequently integrated into the host genome.
This conversion is catalyzed by reverse transcrip-
tase (RT) early after virus entry into the target cell
and is chaperoned by the nucleocapsid protein (NC).
In HIV-1, NC is composed of small basic domains
flanking two highly conserved CCHC zinc fingers
that specifically interact with the genomic RNA and
RT. Through specific interactions with the genomic
RNA and RT, and possibly with cellular factors, the
NC zinc fingers were found to play critical roles in
HIV-1 assembly and budding, and later in proviral
DNA synthesis and integration. Therefore, intact NC
zinc fingers are needed throughout the virus repli-
cation cycle. Here, we report for the first time that
deleting either one or the two NC zinc fingers leads
to an unexpected premature viral DNA synthesis in
virus producer cells and the production of non-
infectious particles with a high level of viral DNA.
In addition to providing the first example of reverse
transcription during the late steps of HIV-1 replica-
tion, these findings emphasize the fact that the
NC zinc fingers are a major target for new drugs
against HIV-1.
INTRODUCTION
Conversion of the positive sense genomic RNA of
retroviruses into DNA is a complex multistep process
that is initiated from a cellular tRNA annealed to the
50 end of the genomic RNA and culminates in the synthesis
of a double-stranded DNA copy of the genomic RNA
ﬂanked by two long terminal repeats (LTR). Reverse
transcription is catalyzed by the viral reverse transcriptase
(RT) present in a large nucleoprotein complex where viral
nucleocapsid protein (NC) molecules coat the genomic
RNA (1,2). NC is encoded by Gag and is a small basic
protein with nucleic acid-binding and chaperoning proper-
ties, found in all retroviruses (3). In lentiviruses, such as
HIV-1, NC is formed of small basic domains ﬂanking two
highly conserved CCHC zinc ﬁngers (4) (Figure 1).
Originally, the intact NC zinc ﬁngers were shown to be
required for genomic RNA packaging (5–8) and later to
be involved in virus assembly and budding (3,9–11). The
selective packaging of the genomic RNA is thought to be
directed by speciﬁc interactions between NC, notably the
zinc ﬁngers, and the packaging Psi signal in the genomic 50
UTR (12). Recently, we observed that disruption of either
one or the two zinc ﬁngers impaired the intracellular Gag
traﬃcking to the budding site, and simultaneously reduced
the levels of Gag processing and of virion production (13)
probably due to a lost interaction with ALIX (14).
NC also plays key roles in the reverse transcription
process that needs its nucleic acid-binding and chaperone
activities and its interaction with RT (3,15). Although
the exact mechanism by which NC facilitates nucleic acid
rearrangements is not completely understood, in vitro
assays mimicking the diﬀerent steps of the reverse
transcription reaction clearly showed that NC chaperones
primer tRNA annealing to the initiation site (PBS), and
the two obligatory strand transfers that are required to
generate the complete proviral DNA ﬂanked by two LTR
(3,16). However, the precise role of the NC zinc ﬁngers in
viral DNA synthesis has been diﬃcult to evaluate in newly
infected cells. Current ﬁndings show that mutating
conserved residues in the ﬁrst or the second CCHC zinc
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reduced DNA synthesis and stability in infected cells, and
a drastic reduction of viral DNA integration (8,17,18).
Interestingly, the reverse-transcription reaction appears
to be tightly controlled during the late steps of HIV-1
replication since the full-length viral DNA (FL DNA)
synthesis is completed only after virions infect target
cells (19). How this is regulated is yet poorly understood.
Since the NC zinc ﬁngers appear to be required through-
out the viral replication cycle, we investigated their role in
the temporal control of reverse transcription. We under-
took a detailed quantitative analysis of the viral nucleic
acid production throughout the replication cycle by qPCR
and qRT–PCR. By measuring the eﬀects of NC zinc ﬁnger
deletions on the conversion of both the genomic and
spliced RNA species into DNA, we discovered that viral
particles released from the cells expressing HIV-1 NC
mutants, contained a high level of DNA. This report
shows for the ﬁrst time that RT can occur in HIV-1-
producing cells, converting HIV-1 into a DNA-like viruses
similar to hepatitis B virus and spumaviruses. Thus, viral
DNA synthesis should be regulated to insure HIV-1
replication in target cells and appears to be a new crucial
role for NC.
MATERIALS AND METHODS
Plasmids, cell culture
The HIV-1 pNL4-3 molecular clone was used to generate
constructs with deletion of ZF1 (pNL4-3ZF1), ZF2
(pNL4-3 ZF 2) or both ZF 1 and ZF 2 (pNL4-3 ZF 1
ZF 2). These mutant constructs have been described
elsewhere (8,13). The human HeLa LTRHIV-1-Luc (20)
(kind gift of S. Emiliani), 293T, HeLa cell lines and the
stably CD4/CXCR4-coexpressing-293 cells (42CD4) (21)
were grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with glutamine (2mM), penicil-
lin, streptomycin and 10% (v/v) heat-inactivated fetal
calf serum.
Transfection, virus preparation and infection
Transfections of 293T cells were performed with 3 10
6
cells divided 1day before in 100mm dishes by calcium
phosphate precipitation with 8mg of HIV-1 plasmid DNA
for 48h. When RT inhibitors were used, 293T cells were
pretreated 3h before transfection with 50mM AZT or
50mM Nevirapine and transfection was pursued for 48h
in presence of the drug. In all cases, 6h after transfection
cells were trypsinized, extensively washed with fresh
medium and divided into a new plate to eliminate plasmid
in excess. The amount of HIV-1 particles in the super-
natant was determined using a HIV-1 CA p24 core antigen
enzyme-linked immunosorbent assay (ELISA) Kit
(Beckman Coulter
TM)o rin vitro standard RT enzyme
assay (22). Virions were puriﬁed from ﬁltered culture
supernatants by centrifugation through a 20% sucrose
cushion at 30000r.p.m. in an SW32 rotor for 1h 30at 48C.
Infections of the 42CD4 cells were performed in
presence of polybrene (2mg/ml) during 24h as previously
described (23).
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Figure 1. Mutations of the NC zinc ﬁnger modify virion morphology, virion release and RNA packaging. Asterisk denotes pictures from electron
microscopy analysis that were from (8,13). Amounts of virion released by the wt and mutant viruses were measured by ELISA assay and in vitro
RT activity assay. Values were normalized to wt levels (mean of n=2). Virion full-length (FL) or multispliced (MS) RNA was determined with
RT–qPCR (mean of n=3) (25).
2312 Nucleic Acids Research, 2008, Vol. 36, No. 7For luciferase reporter assay, virions produced from
transfected 293T cells were quantiﬁed by measuring p24
antigen in culture supernatants (ELISA), puriﬁed and
treated with DNAse. Virion DNA was extracted and used
to transfect HeLa cells stably expressing the HIV-1
promoter/enhancer LTR luciferase construct. HeLa
LTRHIV-1-Luc cells were lyzed 72h posttransfection. Cell
protein extracts were standardized by means of the
Bradford assay and luciferase activity was monitored
using a luminometer.
For the natural endogenous reverse transcription assays
(NERT), the virion-containing media of 293T cells
were removed 44h posttransfection, and cell culture was
incubated for 4h in diﬀerent conditions: standard
medium, medium without FBS (minus dNTP), supple-
mented or not with 100mM dNTP and with or without
50mM Nevirapine (AIDS Research and Reference
Reagent Program, Division of AIDS, NIAID, NIH).
To evaluate the eﬀect of time on NERT, the virions
produced during the 4h of culture in standard medium,
were collected and incubated for an additional 4h in
absence of cells.
DNA and RNA extraction and analysis
Nucleic acids extraction from virions was performed as
previously described (23). Brieﬂy, puriﬁed virions were
incubated with 8 U of DNAse (RQ1, Promega) at 378C
for 45min before extraction of the nucleic acids by phenol/
chloroform and ethanol-precipitated. DNase treatment
reduced contaminations by the transfecting-plasmid
DNA (pNL4-3) under the level of the FL DNA. Thus,
proportions of pNL4-3 in wt and mutant DNA samples
were <20% and 1% of total DNA detected, respectively.
Cellular DNA was extracted with DNAzol (MRC)
according to the manufacturer’s instructions. To avoid
any contamination with viral cDNA associated with the
particles, cells were trypsinized and extensively washed
with PBS before DNA extraction. Cellular RNA was
extracted with TriReagent according to manufacturer’s
instructions. Nucleic acids were quantitated by measuring
optical absorption at 260nm.
To check that intracellular DNA samples were not
contaminated by DNA-containing virions, untransfected
cells were incubated for 24h with supernatant containing
HIV-1 ZF2 virions (issued from 48h production). After
DNA extraction, contaminating multispliced cDNA levels
were determined by qPCR.
In vitro reverse transcription for RT–PCR experiments
was performed as described (24) with oligo(dT) primer
and 1/20 aliquots of virion RNA samples. qPCR was
achieved with 2.5% of the RT-d(T) reaction, or with 50ng
of intravirion and cellular nucleic acid samples.
Systematically, cellular GAPDH gene level was deter-
mined for standardization. qPCR assays were performed
with SYBR Green Kit (Roche) with the RotorGene
(Labgene) systems. A standard curve was generated from
50 to 500000 copies of pNL4.3 plasmid. Each assay
included a control without RT indicating a DNA
contamination level <0.1% of the HIV genomic RNA.
Sequences of primers described in Figure 2 and in (23),
and detailed PCR conditions will be provided on request.
Nucleic acid levels in virion or cell were normalized with
respect to p24 (determined by ELISA) and GAPDH gene,
respectively.
The HIV-1 singly spliced RNAs and corresponding
cDNAs were detected in virions (100ng p24) by standard
PCR (25). In addition to the DNAse treatment of the
puriﬁed virions, an additional DNAse treatment was
performed on nucleic acid extracts to allow speciﬁc
detection of FL RNA by RT–PCR and as a control for
the nature of the viral cDNAs.
RESULTS
Deletions of theNC zinc fingers decreased thepackaging
efficiency of theFL RNA, butnot ofthe viralspliced RNA
To study the control exerted by NC on DNA synthesis by
RT, we used HIV-1 mutants with a deletion of either the
ﬁrst (ZF1), the second (ZF2) or both (ZF1ZF2) NC
zinc ﬁngers and transfected the corresponding DNA in
human 293T cells (Figure 1). As previously reported, the
NC mutant particles were noninfectious and were
produced in reduced amounts containing less genomic
RNA (FL RNA) (Figure 1) (7,8,13). Reduction of
genomic RNA packaging was monitored by qRT–PCR
(Figure 2A) on puriﬁed particles and was found to be from
10% to 1.5% of the wild-type level (Figure 1). In addition,
we examined the packaging of the spliced viral RNAs that
were shown to be speciﬁcally incorporated into HIV-1
particles (25). The NC zinc-ﬁnger deletions did not impair
their packaging (Figures 1 and S1A) and the mutant
particles contained roughly similar levels of genomic and
spliced RNAs (Figure 1).
NC zinc-finger deletions resulted in theaccumulation
ofviral DNA in virions
Infection performed with these mutant particles showed
that the levels of newly made viral DNA were decreased in
target cells (Figure 3, left panel) in agreement with
previous results (8,17,18). Indeed, the canonical view of
reverse transcription is that it mostly takes place in newly
infected cells. However, some reverse transcription can
take place prior to cell entry since low levels of viral DNA
have been found in HIV-1 virions (23,26–30), and termed
NERT for natural endogenous RT. The chaperoning role
of NC protein in reverse transcription suggested to us that
it could regulate the timing of viral DNA synthesis. Thus,
we performed an in-depth analysis of the viral DNA
content in HIV-1 NC mutant particles which have been
extensively treated with DNase to remove any contami-
nant plasmid DNA due to cell transfection, and puriﬁed.
We used qPCR for the quantitative monitoring of ss-
cDNA, Gag and FL DNA. The levels of viral DNA
resulting from reverse transcription of the spliced RNAs
have also been monitored (Figure 2A and B).
Surprisingly, all NC mutant particles contained a high
level of DNA compared with wild-type virions, notably
the ZF2 virions, leading to DNA-to-RNA ratio increase
of up to three orders of magnitude (Figure 3, right panel).
Previously, we found that spliced HIV-1 RNAs were
Nucleic Acids Research, 2008, Vol. 36, No. 7 2313reverse-transcribed as eﬃciently as the genomic RNA (23).
Thus, we also monitored the level of spliced DNAs which
represent an ideal marker for viral DNA quantitation due
to the lack of pNL4.3 plasmid DNA contaminations
(Figure 2A). There was also a drastic enhancement of
spliced cDNAs in these NC mutant virions, with about a
1000-fold increase in the ZF2 particles (Figure 3, right
panel and Figure S1B). Similar results were obtained with
HIV-1 particles obtained by transfecting HeLa cells
(Figure S2).
A careful examination of the newly made virion
DNA shows that a fraction of it corresponded to the
full-length proviral DNA such as in ZF2 virions.
Interestingly, DNA puriﬁed from ZF2 particles was
active once transfected into the reporter cell-line HeLa
LTRHIV-1-Luc since it activated the Tat-mediated lucifer-
ase expression (Figure 4).
Taken together these results suggest that deletion of the
zinc ﬁngers did not impair chaperoning of the reverse
transcription by NC, in agreement with in vitro data (31).
Interestingly, the ZF2 virions contained even higher
amount of viral DNA products (Figure 3, right panel)
than that generated by the wild-type HIV early after cell
infection (Figure 3, left panel). Thus, while the NC zinc
ﬁngers control at least in part genomic RNA packaging,
these conserved NC motifs could also regulate the timing
of viral DNA synthesis during the HIV-1 replication.
Viral DNA inzinc fingermutant virions did notresult
from NERT activity
Thus, we asked whether the virion DNA was produced in
virus particles by a NERT activity somehow stimulated by
the NC zinc-ﬁnger deletions. Stimulation of an otherwise
marginal cDNA synthesis in virions is usually obtained by
adding dNTP to the extracellular milieu together with
virion permeabilization agent (32,33). Because the ZF1,
ZF2 and ZF1ZF2 particles exhibit an abnormal
morphology with a round immature core structure (13)
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Figure 2. Strategy for RT–PCR and PCR analyses of viral RNA and corresponding cDNA. (A) Schematic representation of templates and primers
used for the RT–PCR analyses of HIV-1 RNAs resulting from proviral pNL4-3 plasmid expression. Only the splice sites (SD1/SA5 and SD4/SA7)
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2314 Nucleic Acids Research, 2008, Vol. 36, No. 7(Figure 1), we hypothesized that an abnormal core
structure may confer NERT stimulation through a natural
permeability to the dNTP that are possibly present in the
fetal bovine serum (FBS) of the cell-culture media.
Since the completion of NERT takes place by 4h (27),
the DNA level in NC mutant particles should increase
over time without prior virion permeabilization. However,
the DNA level in particles remained the same with or
without a 4h incubation at 378C (Figure 5A), indicating
that viral DNA synthesis was already complete before
incubation, probably at the time of particles release
from the producer cells. In agreement with this conclu-
sion, addition or deprivation of dNTP or treatment
with the HIV-1 RT inhibitor Nevirapine during the 4h
period of virus production did not inﬂuence levels of the
diﬀerent viral DNA species found in ZF2 particles
(Figure 5B).
Viral DNA was synthesized in HIV-producer cells
To examine whether reverse transcription did take place in
HIV-1 producer cells, we pretreated cells with Nevirapine
3h prior to DNA transfection, and maintained drug
treatment until the viral particles were collected. Under
these conditions, virion release and RNA levels in ZF2
virions were not aﬀected (Figure S3), but ss-cDNA, Gag
and FL DNAs and spliced cDNAs were all found in very
low quantities in HIV-1 ZF2 virions (Figures 6, S1C and
S4A). Similar results were obtained with AZT, except as
expected for the initial ss-cDNA product that is known to
be poorly responsive to the AZT chain terminator (23,34)
(Figures S3 and S4B). Taken together, these ﬁndings
indicate that viral DNA synthesis can take place in cells
producing HIV-1 zinc ﬁnger mutant particles.
This prompted us to investigate whether newly made
ss-cDNA, Gag and FL DNAs were present in HIV-1
producer cells. However, despite extensive DNase treat-
ment of these cells, there was residual plasmid DNA
present in the transfected cells. To circumvent this
diﬃculty we analyzed the levels of spliced cDNAs
corresponding to the reverse transcription of the spliced
viral RNAs. As shown in Figure 7A, spliced viral cDNAs
were abundant in cells transfected with the ZF2 mutant
DNA, but not in those transfected with the wild-type
HIV-1 DNA. In support of this, addition of the RT
inhibitor Nevirapine or AZT prevented spliced cDNA
synthesis in these producer cells (Figures 7B and S5).
Upon HIV-1 infection, the double-stranded linear FL
DNA is synthesized and the ends can be joined by host
ligases generating 2-LTR-circles (35,36). Therefore, detec-
tion of circular DNA with an LTR–LTR junction in the
ZF2 transfected-cell (Figure 7C) indicates that some of
the reverse transcripts made in producer cells are double-
stranded full-length molecules. Our data clearly showed
that NC zinc-ﬁnger mutation did not interfere with bona
ﬁde reverse transcription process but caused viral DNA
synthesis to take place in HIV-1-producing cells, and to
generate DNA-containing particles (Figure 8).
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Soon after infection, viral DNA synthesis is thought to
take place within reverse transcription complexes (RTC)
containing mature RT, integrase (IN), Vpr, the genomic
RNA and NC protein molecules (3,37). The ﬁndings
reported here favor the notion that the conserved NC zinc
ﬁngers exert, either directly or indirectly, a control over
the timing of viral DNA synthesis during the late stages of
HIV-1 replication. The start of viral DNA synthesis
probably follows viral core formation and processing, and
necessitates mature RT protein (38–40).
In producer cells, there is an accumulation of Gag and
Gag-Pol precursors, containing NC and RT domains,
respectively. Nevertheless, mature viral proteins and
enzymes are also most probably present as indicated by
the detection of mature capsid protein (p24) in HIV-
1-producer cells [see for examples (13,14,41,42)]. In
addition, both Gag and Gag-Pol precursors can also
contribute to the reverse transcription reaction. The RT
domain of Pol, which has some enzymatic activity (43),
can select the replication tRNALys3 primer (44,45). The
Gag–NC was found to chaperone primer tRNALys3
annealing to the genomic primer-binding site (PBS) (46)
that is required for the initiation of cDNA synthesis
by RT. Such a cellular environment should allow the
start of viral reverse transcription and thus the presence
of viral DNA in newly formed virions (47) (Figure 3,
right panel).
Gag–NC is also implicated in the protease-mediated
processing of Gag via its binding to the viral RNA
(42,48,49). Although Gag processing was partially
impaired when the NC zinc ﬁngers were deleted, mature
viral proteins were still easily detected in cells expressing
the NC zinc ﬁngers mutants (13,42) and could then
endorse the late RT activity observed in cells producing
HIV-1 with deleted NC zinc ﬁngers.
Interestingly, the NC zinc ﬁngers are important
determinants that are also involved in the control of
HIV-1 assembly, traﬃcking and budding (3,11,50).
During these processes, the NC domain mediates impor-
tant protein–protein interactions with other viral proteins
such as Gag-Pol, Vpr and Vif (51), and with cellular
proteins, actin (52), ALIX (14), topoisomerase I (53),
Staufen (54) and APOBEC3G (3,10). These multiple Gag–
NC functions likely contribute to the temporal ﬁne-tuning
of the replication steps including the timing of RT
(Figure 8).
Then, how could we tentatively explain that viral
DNA synthesis can take place in cells producing HIV-1
particles harboring a deletion in either one of the two zinc
ﬁngers?
The kinetics of the concerted HIV-1 assembly and
budding processes might be slowed down by zinc ﬁnger
deletions, allowing more time for viral DNA synthesis
before particle release. Indeed, mutating or deleting the
NC zinc ﬁngers reduced the production of the NC mutant
viral particles (Figure 1) with a drastic change in Gag
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2316 Nucleic Acids Research, 2008, Vol. 36, No. 7localization (13). More precisely, they caused an accumu-
lation of Gag in the cytoplasm or at the plasma
membrane, but not at the level of late endosomes as for
wild-type Gag (13), probably due to the fact that Gag–NC
interactions with genomic RNA and with the cellular
budding factor ALIX were impaired (14). Thus, we favor
the notion that late RT is taking place in core structures
formed of nonprocessed and processed Gag and Gag-Pol
molecules. According to electron microscopy analysis of
NC mutant cores (8,13) (Figure 1), it is likely that such
intracellular viral core complexes are poorly condensed
thus facilitating the reverse transcription reaction.
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Figure 7. Large amounts of viral DNA in HIV-1 ZF2-producing cells. (A) Spliced viral cDNAs were measured by qPCR in 293T cells transfected
or not with ZF2 or wild-type plasmids (n=3 SD). (B) Eﬀects of Nevirapine (50mM) and AZT (50mM) treatments on spliced viral cDNA levels
were measured by qPCR in 293T cells producing ZF2 virions (n=3 SD). (C) Circular DNA forms were detected by PCR with primers ﬂanking
the 2LTR junction in both the infected cells (42CD4) and transfected cells (293T). All DNA samples were normalized to GAPDH gene copy number.
A representative experiment is shown.
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Figure 8. Cartoon depicting conceptual diﬀerences between early and late RT activation during HIV-1 replication with intact NC or with a deletion
of an NC zinc ﬁnger.
Nucleic Acids Research, 2008, Vol. 36, No. 7 2317An alternative mechanism by which zinc ﬁnger muta-
tions may stimulate late RT is the alleviation of
cofactor(s) activity that negatively regulates RT. Several
studies reported a Vif/APOBEC related regulation of the
RT (51,55–57). These two proteins interact directly with
Gag–NC and genomic RNA (58–60). Interestingly, Vif
shares RNA chaperone activity with NC and Gag–NC
proteins (51). Thus, in the context of the 293T cells in
which APOBEC is poorly expressed, Vif may compete
with NC-associated functions in assembly complexes and
RTC. Indeed, in vitro Vif inhibits the NC-mediated
tRNALys3 annealing and the initiation of RT (51).
Then, Vif inhibitory eﬀect could be relieved by the
deletion of the NC zinc ﬁngers which prevents Gag–NC/
Vif interactions, and consequently, late RT could be
stimulated by Gag–NC. It will thus be of interest to
investigate viral DNA synthesis in cells expressing HIV-1
NC mutants and APOBEC3G.
The occurrence of late RT inside producer cells is also a
property of the hepadnaviruses (e.g. hepatitis B virus) and
foamy viruses which lack NC zinc ﬁngers and release viral
DNA-containing particles (61). Even though the life cycle
of the simian foamy virus is poorly understood (62), the
fact that HIV-1 NC zinc ﬁnger mutants could engage a
similar DNA replication strategy (Figure 8) constitutes a
fundamental issue and could bring an alternative explana-
tion for the presence of viral DNA in HIV-1 particles
isolated from the peripheral blood and semen of HIV-1-
infected patients (29,47).
Last, these new ﬁndings on the role of HIV-1 further
highlight the fact that the conserved zinc ﬁnger motifs
should be viewed as a major target for new drugs inhibiting
both the late and early steps of HIV-1 replication (3,63).
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